Clinical Trial Update: Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study [Phase 3]

View source ↗

Summary

Phase 3 study evaluating autologous muscle-derived cells for female stress urinary incontinence has completed and posted results in May 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence
• Urinary Incontinence

Drugs mentioned

• MyoCell (autologous skeletal myoblasts)

Snippet

Sponsor: Cook MyoSite | Conditions: Urinary Incontinence, Stress | Phase 3 | Status: COMPLETED | Results posted: 2018-05-17